# TCF7

## Overview
TCF7, or T cell factor 7, is a gene that encodes a transcription factor belonging to the TCF/LEF family, which plays a pivotal role in the regulation of gene expression. The protein product, transcription factor 7, is integral to the Wnt/β-catenin signaling pathway, acting as a transcriptional regulator that influences various cellular processes, including T cell development and differentiation. TCF7 is characterized by its conserved structure, which includes domains essential for DNA binding and protein interactions, such as the high-mobility group (HMG) box and the β-catenin binding domain. The gene's expression and function are critical in immune system development, particularly in T-lineage cells, and its dysregulation is implicated in several malignancies and immune disorders, highlighting its significance in both normal physiology and disease states (Zhu2015Roles; Hoppler2014Evolutionary; Yu2012The).

## Structure
The TCF7 protein, a member of the TCF/LEF family, is characterized by a conserved exon structure inherited from a prevertebrate ancestral TCF gene. It typically consists of 12 exons, with functional domains corresponding to these exons. The primary structure includes an N-terminus containing the β-catenin binding domain (BCBD), a core DNA-binding domain known as the high-mobility group (HMG) box, a context-dependent regulatory domain (CDRD), and a C-terminal tail (Hoppler2014Evolutionary).

The secondary structure of TCF7 involves the HMG box, which is crucial for DNA binding. This domain is relatively conserved across different isoforms, which are generated through alternative splicing. The tertiary structure involves the 3D folding of these domains, allowing interactions with other proteins, such as β-catenin, to mediate transcriptional activation or repression (Hoppler2014Evolutionary).

Alternative splicing significantly affects the C-terminal region, resulting in different isoforms like the 'E-tail' with a complete C-clamp domain, the 'B-tail' lacking C-clamp sequences, and the 'C-tail' with a disrupted C-clamp. The C-clamp is an auxiliary DNA-binding domain that recognizes GC-rich sequences and is encoded by conserved exons XI and XII (Hoppler2014Evolutionary). These structural variations suggest evolutionary adaptations that enable TCF7 to participate in diverse regulatory networks.

## Function
TCF7, also known as transcription factor 7, is a critical transcription factor involved in the development and differentiation of T-lineage cells. It plays a pivotal role in T cell specification, particularly in the thymus, where it is highly upregulated in early thymic progenitors. TCF7 promotes the expression of T-lineage genes and is essential for the proliferation and survival of thymocytes, as well as their transition from double negative (DN) to double positive (DP) stages (Zhu2015Roles; Weber2011A).

In peripheral tissues, TCF7 influences the differentiation of CD4+ T cells into Th2 cells while suppressing Th1 and Th17 cell fates. It also supports the formation of memory CD8+ T cells (Zhu2015Roles). TCF7 interacts with the Wnt/β-catenin signaling pathway, forming a transcription complex with β-catenin to regulate T cell development and survival (Zhu2015Roles).

TCF7 is also involved in the regulation of Tc17 cells, a subset of CD8+ T cells that produce IL-17. It suppresses the formation of these cells by repressing the maf–rorγt axis, thereby influencing the chromatin state and gene expression profiles associated with Tc17 differentiation (Mielke2019TCF1).

## Clinical Significance
Alterations in the expression of the TCF7 gene, also known as transcription factor 7, have been implicated in various diseases, particularly in the context of malignancies and immune disorders. In T cell development, TCF7 plays a crucial role, and its deficiency is associated with the development of T cell lymphoblastic lymphomas. TCF7-deficient mice exhibit increased expression of oncogenic factors such as Id2 and LEF-1, contributing to lymphoma development (Yu2012The). In human T cell acute lymphoblastic leukemia (T-ALL), particularly the early T-cell precursor subtype (ETP-ALL), decreased TCF7 expression is linked to poor prognosis, with some cases showing a single copy loss of the TCF7 gene region (Yu2012The).

In chronic lymphocytic leukemia (CLL), TCF7 expression is significantly lower in patients compared to healthy individuals, correlating with a poor prognosis and shorter time to first treatment (TTFT) and overall survival (OS) (Liang2022Decreased). TCF7 is also involved in colorectal cancer, where its expression is associated with WNT/β-catenin signaling and cell migration, suggesting a role in metastasis (Mayer2020Diverse). These findings highlight the clinical significance of TCF7 in various cancers and its potential as a biomarker for disease progression and prognosis.

## Interactions
TCF7, a transcription factor, is involved in several key interactions that regulate its function in cellular processes. TCF7 interacts with β-catenin, a crucial component of the Wnt signaling pathway, to regulate gene expression. This interaction is essential for TCF7's role in chromatin occupancy and transcriptional activation of Wnt target genes (Han2017Ubiquitin). TCF7 also forms a complex with ubiquitin C-terminal hydrolase 37 (Uch37), which deubiquitinates TCF7, enhancing its DNA-binding ability without affecting its stability. This interaction is critical for the activation of Wnt signaling and the expression of target genes during embryogenesis and in certain cancer cells (Han2017Ubiquitin).

In the context of T-cell acute lymphoblastic leukemia (T-ALL), TCF7 forms a fusion with SPI1, which requires β-catenin activity to drive leukemogenesis. The TCF7-SPI1 fusion interacts with β-catenin to regulate gene expression, and this interaction is crucial for the oncogenic function of the fusion protein (Van2021Oncogenic). TCF7 also interacts with the architectural protein CTCF, influencing the 3D chromatin structure in T cell progenitors, which is important for chromatin interactions and gene regulation (Wang2022TCF-1).


## References


[1. (Mielke2019TCF1) Lisa A. Mielke, Yang Liao, Ella Bridie Clemens, Matthew A. Firth, Brigette Duckworth, Qiutong Huang, Francisca F. Almeida, Michael Chopin, Hui-Fern Koay, Carolyn A. Bell, Soroor Hediyeh-Zadeh, Simone L. Park, Dinesh Raghu, Jarny Choi, Tracy L. Putoczki, Philip D. Hodgkin, Ashley E. Franks, Laura K. Mackay, Dale I. Godfrey, Melissa J. Davis, Hai-Hui Xue, Vanessa L. Bryant, Katherine Kedzierska, Wei Shi, and Gabrielle T. Belz. Tcf-1 limits the formation of tc17 cells via repression of the maf–rorγt axis. Journal of Experimental Medicine, 216(7):1682–1699, May 2019. URL: http://dx.doi.org/10.1084/jem.20181778, doi:10.1084/jem.20181778. This article has 49 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20181778)

[2. (Zhu2015Roles) Yichun Zhu, William Wang, and Xiangdong Wang. Roles of transcriptional factor 7 in production of inflammatory factors for lung diseases. Journal of Translational Medicine, August 2015. URL: http://dx.doi.org/10.1186/s12967-015-0617-7, doi:10.1186/s12967-015-0617-7. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-015-0617-7)

[3. (Hoppler2014Evolutionary) Stefan Hoppler and Marian L. Waterman. Evolutionary diversification of vertebrate tcf/lef structure, function, and regulation. March 2014. URL: http://dx.doi.org/10.1002/9781118444122.ch17, doi:10.1002/9781118444122.ch17. This article has 10 citations.](https://doi.org/10.1002/9781118444122.ch17)

[4. (Van2021Oncogenic) Quentin Van Thillo, Jolien De Bie, Janith A. Seneviratne, Sofie Demeyer, Sofia Omari, Anushree Balachandran, Vicki Zhai, Wai L. Tam, Bram Sweron, Ellen Geerdens, Olga Gielen, Sarah Provost, Heidi Segers, Nancy Boeckx, Glenn M. Marshall, Belamy B. Cheung, Kiyotaka Isobe, Itaru Kato, Junko Takita, Timothy G. Amos, Ira W. Deveson, Hannah McCalmont, Richard B. Lock, Ethan P. Oxley, Maximilian M. Garwood, Ross A. Dickins, Anne Uyttebroeck, Daniel R. Carter, Jan Cools, and Charles E. de Bock. Oncogenic cooperation between tcf7-spi1 and nras(g12d) requires β-catenin activity to drive t-cell acute lymphoblastic leukemia. Nature Communications, July 2021. URL: http://dx.doi.org/10.1038/s41467-021-24442-9, doi:10.1038/s41467-021-24442-9. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-24442-9)

[5. (Liang2022Decreased) Taotao Liang, Xiaojiao Wang, Yanyan Liu, Hao Ai, Qian Wang, Xianwei Wang, Xudong Wei, Yongping Song, and Qingsong Yin. Decreased tcf1 and bcl11b expression predicts poor prognosis for patients with chronic lymphocytic leukemia. Frontiers in Immunology, September 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.985280, doi:10.3389/fimmu.2022.985280. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.985280)

[6. (Wang2022TCF-1) Wenliang Wang, Aditi Chandra, Naomi Goldman, Sora Yoon, Emily K. Ferrari, Son. C. Nguyen, Eric F. Joyce, and Golnaz Vahedi. Tcf-1 promotes chromatin interactions across topologically associating domains in t cell progenitors. Nature Immunology, 23(7):1052–1062, June 2022. URL: http://dx.doi.org/10.1038/s41590-022-01232-z, doi:10.1038/s41590-022-01232-z. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41590-022-01232-z)

[7. (Weber2011A) Brittany Nicole Weber, Anthony Wei-Shine Chi, Alejandro Chavez, Yumi Yashiro-Ohtani, Qi Yang, Olga Shestova, and Avinash Bhandoola. A critical role for tcf-1 in t-lineage specification and differentiation. Nature, 476(7358):63–68, August 2011. URL: http://dx.doi.org/10.1038/nature10279, doi:10.1038/nature10279. This article has 331 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature10279)

[8. (Yu2012The) Shuyang Yu, Xinyuan Zhou, Farrah C. Steinke, Chengyu Liu, Shann-Ching Chen, Oksana Zagorodna, Xuefang Jing, Yoshifumi Yokota, David K. Meyerholz, Charles G. Mullighan, C. Michael Knudson, Dong-Mei Zhao, and Hai-Hui Xue. The tcf-1 and lef-1 transcription factors have cooperative and opposing roles in t cell development and malignancy. Immunity, 37(5):813–826, November 2012. URL: http://dx.doi.org/10.1016/j.immuni.2012.08.009, doi:10.1016/j.immuni.2012.08.009. This article has 154 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2012.08.009)

[9. (Mayer2020Diverse) Claus-Dieter Mayer, Soizick Magon de La Giclais, Fozan Alsehly, and Stefan Hoppler. Diverse lef/tcf expression in human colorectal cancer correlates with altered wnt-regulated transcriptome in a meta-analysis of patient biopsies. Genes, 11(5):538, May 2020. URL: http://dx.doi.org/10.3390/genes11050538, doi:10.3390/genes11050538. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes11050538)

[10. (Han2017Ubiquitin) Wonhee Han, Hyeyoon Lee, and Jin-Kwan Han. Ubiquitin c-terminal hydrolase37 regulates tcf7 dna binding for the activation of wnt signalling. Scientific Reports, February 2017. URL: http://dx.doi.org/10.1038/srep42590, doi:10.1038/srep42590. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep42590)